O’Melveny is home to some of the nation’s preeminent practitioners in Hatch-Waxman and biologics litigation.  Offering the technical depth of an intellectual property boutique, coupled with the resources of an elite global litigation powerhouse, our team provides unparalleled service to innovator companies.

As scientists, and litigators, we know the pharmaceutical industry.  We know chemistry.  We know biotechnology.  We know formulation technology.  We know the law.  And we know the regulatory environment.  Our team has handled dozens of significant cases for drug manufacturers whose patents were threatened by generic challengers, and protected billions in sales revenue.